SCHEMBL8282808

SCHEMBL8282808

CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCCC(C)C1

nearest known ligand 0.85

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 19/20 0.85
CTSD P07339 16/20 0.85
CYP3A4 P08684 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5669863 1.00 BACE1 (0.85) BACE1CTSDCYP3A4
SCHEMBL5734632 0.94 BACE1 (0.74) BACE1CTSD
SCHEMBL8282585 0.93 BACE1 (0.72) BACE1CTSD
SCHEMBL5666841 0.93 BACE1 (0.72) BACE1CTSD
SCHEMBL5667251 0.92 BACE1 (0.88) BACE1CTSDCYP3A4
SCHEMBL8282604 0.92 BACE1 (0.88) BACE1CTSDCYP3A4
SCHEMBL3171968 0.91 BACE1 (1.00) BACE1CTSD
SCHEMBL13315987 0.91 BACE1 (1.00) BACE1CTSD
SCHEMBL3177992 0.91 BACE1 (1.00) BACE1CTSD
SCHEMBL3168303 0.91 BACE1 (1.00) BACE1CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005070407-A1 METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INIHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2005-08-04 WO disclosed